Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, Extranodal NK-T-Cell × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Urinary Bladder Neoplasms 12 Neoplasms 10 Carcinoma, Renal Cell 9 Ovarian Neoplasms 7 Carcinoma, Transitional Cell 7 Neoplasm Metastasis 6 Pancreatic Neoplasms 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Merkel Cell 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Lymphoma 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1

Interventions

fludarabine phosphate 19 Peripheral Blood Stem Cell Transplantation 15 Cyclophosphamide 15 Whole-Body Irradiation 14 Tacrolimus 13 Mycophenolic Acid 13 Busulfan 12 Antilymphocyte Serum 11 Rituximab 9 Etoposide 7 Methotrexate 6 Cyclosporine 6 Melphalan 5 thymoglobulin 4 Flow Cytometry 4 Carboplatin 4 Therapeutics 3 Radiotherapy 3 Lenalidomide 3 In Situ Hybridization, Fluorescence 3 Immunohistochemistry 3 Gene Expression Profiling 3 Filgrastim 3 Everolimus 3 Amplified Fragment Length Polymorphism Analysis 3 Alemtuzumab 3 fludarabine 2 Vorinostat 2 Vincristine 2 Transplantation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡